Response assessment in gastrointestinal
✍
Jayesh Desai
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
French
⚖ 475 KB
## Abstract Imatinib is standard first‐line treatment for patients with advanced gastrointestinal stromal tumor (GIST). Initial responses are not always accompanied by reductions in tumor size; consequently, other parameters should be considered in response assessments. Conventional size‐based crit